System is seeking earned authority.
What’s happening: The vertically integrated peptide platform announced $20M to scale its transparency-focused, consumer-first model.
Supply. Securing every link in the supply chain, System connects US-based raw ingredient manufacturers and certified compounding pharmacies to licensed clinicians and their patients.
Prescribing stacks including glutathione, GHK-CU, MIC + B12, NAD+, and sermorelin, it aims to provide trusted access to consumers seeking enhanced energy, metabolism, and longevity.
Demand. Already a multi-billion-dollar gray market, reports of tainted peptides, imprecise dosages, and adverse reactions have risen alongside consumer adoption.
As the FDA readies a safer legal pathway, System is pro-regulation by design, using only third-party-tested peptides, background-checked doctors, and FDA-registered pharmacies — a point it believes will win users left unserved by concierge clinics and overseas pill mills.
Not alone, DTC platforms are scaling peptide infrastructure—tapping vertical integration and sleek branding—to fill gaps in traditional care.
Looking ahead: As peptides become the new supplements, users will search for a trusted supply chain.
